Alan H. Bryce

Also affiliated with City of Hope, Mayo Clinic Hospital, Goodyear (United States)

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile

14.6Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics

Cell(2018)10.1016/j.cell.2018.02.052

Top 2%

8.1DataRank

Top 2%3980 citations

Katherine A. Hoadley, Laila M. Poisson, Alexander J. Lazar, Andrew D. Cherniack, Albert J. Kovatich +866 more

Papers

Driven by 27 papers — median percentile 98. Top paper: “An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics”.

An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics

Cell(2018)10.1016/j.cell.2018.02.052

Top 2%

8.1DataRank

Top 2%3980 citations

Katherine A. Hoadley, Laila M. Poisson, Alexander J. Lazar, Andrew D. Cherniack, Albert J. Kovatich +866 more

Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics

Cell(2018)10.1016/j.cell.2018.03.033

Top 3%

6.4DataRank

Top 3%447 citations

Matthew H. Bailey, Hoifung Poon, Vesteinn Thorsson, Antonio Colaprico, Andreas Bender +883 more

Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas

Cell Reports(2018)10.1016/j.celrep.2018.03.046

N/A

5.5DataRank · unranked

186 citations

Francisco Sanchez-Vega, Konnor C. La, Joshua Armenia, Walid K. Chatila, Augustin Luna +869 more

Oncogenic Signaling Pathways in The Cancer Genome Atlas

Cell(2018)10.1016/j.cell.2018.03.035

N/A

1.2DataRank · unranked

3322 citations

Marco Mina, Joshua Armenia, Walid K. Chatila, Augustin Luna, Konnor C. La +891 more

Rucaparib for the Treatment of Metastatic Castration-resistant Prostate Cancer Associated with a DNA Damage Repair Gene Alteration: Final Results from the Phase 2 TRITON2 Study

European Urology(2023)10.1016/j.eururo.2023.05.021

N/A

0.695DataRank · unranked

102 citations

David Campbell, Akash Patnaik, Alan H. Bryce, Jeremy Shapiro, Richard M. Bambury +25 more

FOXA1 overexpression suppresses interferon signaling and immune response in cancer

Journal of Clinical Investigation(2021)10.1172/jci147025

N/A

0.678DataRank · unranked

91 citations

Liguo Wang, Ting Wei, Yu‐Tian Xiao, Haoyue Sheng, Hengchuan Su +24 more

Tumor Frameshift Mutation Proportion Predicts Response to Immunotherapy in Mismatch Repair-Deficient Prostate Cancer

The Oncologist(2020)10.1002/onco.13601

N/A

0.612DataRank · unranked

58 citations

Julia Fountain, Pedro Isaacsson Velho, Su Jin Lim, Hao Wang, Emily Nizialek +15 more

Expert Perspectives on Controversies in Castration-Sensitive Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 1

JU Open Plus(2024)10.1097/ju9.0000000000000137

N/A

0.457DataRank · unranked

8 citations

Alan H. Bryce, Maha Hussain, Neeraj Agarwal, Himisha Beltran, Matthew R. Cooperberg +33 more

Co-occurring BRCA2/SPOP Mutations Predict Exceptional Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer

European Urology Oncology(2023)10.1016/j.euo.2023.11.014

N/A

0.442DataRank · unranked

18 citations

Fadi Taza, Navonil De Sarkar, Alok K. Tewari, Syed Arsalan Ahmed Naqvi, Irbaz Bin Riaz +32 more

Molecular Profile Changes in Patients with Castrate-Resistant Prostate Cancer Pre- and Post-Abiraterone/Prednisone Treatment

Molecular Cancer Research(2022)10.1158/1541-7786.mcr-22-0099

N/A

0.434DataRank · unranked

17 citations

Krishna R. Kalari, Sisi Qin, Scott M. Dehm, Vipul Bhargava, Michael Gormley +12 more

Three- and Seven-month Prostate-specific Antigen Levels as Prognostic Markers for Overall Survival in Metastatic Hormone-sensitive Prostate Cancer: Results from SWOG S1216, a Phase 3 Randomized Trial of Androgen Deprivation Plus Orteronel or Bicalutamide

European Urology Oncology(2024)10.1016/j.euo.2024.03.001

N/A

0.345DataRank · unranked

9 citations

Catherine M. Tangen, Maha Hussain, Shilpa Gupta, Sam Callis, Yeonjung Jo +17 more

Recent and Future Developments in the Use of Poly (ADP-ribose) Polymerase Inhibitors for Prostate Cancer

European Urology Oncology(2024)10.1016/j.euo.2024.11.011

N/A

0.330DataRank · unranked

8 citations

Wassim Abida, Emmanuel S. Antonarakis, Alan H. Bryce, Elena Castro, Heather H. Cheng +3 more

Expert Perspectives on Controversies in Metastatic Castration-Resistant Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 2

JU Open Plus(2024)10.1097/ju9.0000000000000138

N/A

0.208DataRank · unranked

3 citations

E. David Crawford, Neeraj Agarwal, Maha Hussain, Himisha Beltran, Matthew R. Cooperberg +33 more

Prostate-specific antigen value at 3 & 7 months (PSA-3mo, PSA-7mo) and overall survival (OS) in metastatic hormone-sensitive prostate cancer (mHSPC) treated with androgen deprivation (ADT) with or without orteronel (SWOG S1216).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5074

N/A

0.165DataRank · unranked

2 citations

Catherine M. Tangen, Maha Hussain, Shilpa Gupta, Yeonjung Jo, Andrea Harzstark +15 more

The prognostic value of androgen to PSA ratio in predictive modeling of prostate cancer

Medical Hypotheses(2023)10.1016/j.mehy.2023.111084

N/A

0DataRank · unranked

4 citations

Allison Weber, Alan H. Bryce, Yang Kuang, Tin Phan

FOXA1 overexpression suppresses interferon signaling and immune response in cancer

UNC Libraries(2024)10.17615/pg5w-dx64

N/A

0DataRank · unranked

0 citations

Xuegong Zhang, Yakun Yan, Tao Wei, D.P Hollern, JC Boughey +23 more

Heterogeneity of the Treatment Effect with PARP Inhibitors in Metastatic Castration-resistant Prostate Cancer: A Living Interactive Systematic Review and Meta-analysis

European Urology(2025)10.1016/j.eururo.2024.12.007

N/A

0DataRank · unranked

36 citations

Irbaz Bin Riaz, Arifa Bibi, Muhammad Ali Khan, Manal Imran, Kaneez Zahra Rubab Khakwani +16 more

Systemic treatment options for metastatic castration resistant prostate cancer: A living systematic review

medRxiv(2025)10.1101/2025.04.15.25325837

N/A

0DataRank · unranked

0 citations

Muhammad Umair Anjum, Arifa Bibi, Muhammad Ali Khan, Kaneez Zahra Rubab Khakwani, Huan He +19 more

Targeting TMPRSS2 in SARS-CoV-2 Infection

Mayo Clinic Proceedings(2020)10.1016/j.mayocp.2020.06.018

N/A

0DataRank · unranked

143 citations

Neeraj Sharma, Eran Elhaik, Aleksandar Sekulić, Alan H. Bryce, Rafaël Fonseca +1 more

Review: Mathematical Modeling of Prostate Cancer and Clinical Application

Applied Sciences(2020)10.3390/app10082721

N/A

0DataRank · unranked

50 citations

Sharon Crook, Alan H. Bryce, Carlo C. Maley, Eric J. Kostelich, Yang Kuang +1 more

Associations of Cutaneous Immune-Related Adverse Effects of Immunotherapy With Treatment Response in Patients With Metastatic Melanoma

SKIN The Journal of Cutaneous Medicine(2021)10.25251/skin.5.2.5

N/A

0DataRank · unranked

2 citations

Alan H. Bryce, Prakash Vishnu, Svetomir N. Markovic, Marian T. McEvoy, Anagha Kumar

Analysis of fragment ends in plasma DNA from patients with cancer

medRxiv(2021)10.1101/2021.04.23.21255935

N/A

0DataRank · unranked

9 citations

Bradon R. McDonald, Michelle D. Stephens, Tania Contente‐Cuomo, Havell Markus, Maria Farooq +17 more

Differential responses to taxanes and PARP inhibitors (PARPi) in ATM- versus BRCA2-mutated metastatic castrate-resistant prostate cancer (mCRPC) patients (pts).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.5040

N/A

0DataRank · unranked

0 citations

Emily Nizialek, Jacob E. Berchuck, Panagiotis J. Vlachostergios, Ryan Ashkar, Alexandra Sokolova +14 more

Disparities in Representation of Women, Older Adults, and Racial/Ethnic Minorities in Immune Checkpoint Inhibitor Trials

The American Journal of Medicine(2022)10.1016/j.amjmed.2022.03.042

N/A

0DataRank · unranked

27 citations

Mahnoor Islam, Ahsan Masood Khan, Syed Arsalan Ahmed Naqvi, Rabbia Siddiqi, Kaneez Zahra Rubab Khakwani +11 more

Biomarkers for Predicting Abiraterone Treatment Outcome and Selecting Alternative Therapies in Castration‐Resistant Prostate Cancer

Clinical Pharmacology & Therapeutics(2022)10.1002/cpt.2582

N/A

0DataRank · unranked

12 citations

Huanyao Gao, Wootae Kim, Huan Zhang, Yayun Gu, Krishna R. Kalari +13 more

Genome-wide analysis of aberrant position and sequence of plasma DNA fragment ends in patients with cancer

Science Translational Medicine(2023)10.1126/scitranslmed.abm6863

N/A

0DataRank · unranked

59 citations

Bradon R. McDonald, Michelle D. Stephens, Tania Contente‐Cuomo, Havell Markus, Maria Farooq +17 more

Approaches to Prevent and Manage Cardiovascular Disease in Patients Receiving Therapy for Prostate Cancer

Current Cardiology Reports(2023)10.1007/s11886-023-01909-3

N/A

0DataRank · unranked

13 citations

Hilda M. Gonzalez Bonilla, Alan H. Bryce, Parminder Singh, Joerg Herrmann, Choon Ta Ng

Alan H. Bryce

Indexed papers

Top data-sharing exemplar

Papers